Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

NCT03477864 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was not accruing

Conditions

Stage III Prostate Cancer
Stage IIIA Prostate Cancer
Stage IIIB Prostate Cancer
Stage IIIC Prostate Cancer
Stage IV Prostate Cancer
Stage IVA Prostate Cancer
Stage IVB Prostate Cancer

Interventions

BIOLOGICAL: Ipilimumab
RADIATION: Stereotactic Body Radiation Therapy (SBRT)
PROCEDURE: Radical Prostatectomy
BIOLOGICAL: Anti-PD-1 Monoclonal Antibody REGN2810

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]
[object Object]